✦ LIBER ✦

Gemcitabine and vinorelbine chemotherapy for refractory or relapsing aggressive non-Hodgkin lymphoma

✍ Scribed by Vanessa Sivam; Lucy Cook; George Hughes; Anasatasios Karadimitris; Alexandra J. Marks; Francis Matthey; Kikkeri N. Naresh; Richard M. Szydlo; Helen Yarranton; Edward J. Kanfer; Donald H. Macdonald

Book ID: 112098355
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 154 KB
Volume: 30
Category: Article
ISSN: 0278-0232
DOI: 10.1002/hon.2011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine-based combination chemothera

Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma

✍ Shih-Hung Yang; Zhong-Zhe Lin; Sung-Hsin Kuo; Ann-Lii Cheng 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB 👁 1 views

Gemcitabine, vinorelbine and prednisone

Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma,results of a phase II single center study

✍ Hannes Müller-Beißenhirtz; Christoph Kasper; Holger Nückel; Ulrich Dührsen 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 85 KB

Ifosfamide, etoposide, cytarabine, and m

Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma

✍ Aspasia Stamatoullas; Christophe Fruchart; Dominique Bastit; Dominique Boulet; M 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

Low-dose weekly paclitaxel for recurrent

Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma

✍ David A. Rizzieri; Gregory J. Sand; Dean McGaughey; Joseph O. Moore; Carlos DeCa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

## Abstract ## BACKGROUND Many patients with recurrent, intermediate or high‐grade non‐Hodgkin lymphoma (NHL) may not respond to or are not candidates for aggressive salvage chemotherapy. Effective, less toxic regimens are needed. Although high‐dose taxanes have not been reported to be very effect

Allogeneic haematopoietic stem-cell tran

Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma

✍ Richard T. Doocey; Cynthia L. Toze; Joseph M. Connors; Thomas J. Nevill; Randy D 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

A multicenter phase 2 study of risk-adju

A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma

✍ Sant-Rayn Pasricha; Andrew Grigg; John Catalano; Michael Leahy; Craig Underhill; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

## Abstract ## BACKGROUND. Administration of salvage chemotherapy to patients with relapsed or refractory lymphoma is associated with significant toxicity. Vinorelbine and gemcitabine are novel chemotherapeutic agents with minimal overlapping toxicity. We present a phase 2 study of vinorelbine and